2019/11/13
Medical Product Registration is applicable to Risk Class II products and has its regulatory requirements determined by ANVISA Resolution RDC 40: 2015. The products with the lowest risk are classified in Risk Class I, and for this they require Notification with ANVISA, in accordance with the requirements of ANVISA Resolution RDC 270: 2019. The main difference […]